Clinical trial
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating…
NCT00014469 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00014469 |
|---|---|
| Title | Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer |
| Official title | A Phase II Trial of IV Busulfan (Busulfex) and Melphalan as a Preparatory Regimen Prior to Allogeneic Bone Marrow Transplantation for the Treatment of Advanced and High Risk Hematologic Malignancies |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Drug, Procedure |
| Interventions | busulfan, melphalan, methotrexate, tacrolimus, allogeneic bone marrow transplantation |
| Start date | Dec 1, 2000 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: